Home » Topics » Regulatory

Regulatory
RSS

Glybera gene therapy approved by the European Commission

Nov. 5, 2012

FDA grants first approval to ocriplasmin

Oct. 18, 2012

FDA approves Abraxane for NSCLC

Oct. 15, 2012

FDA approves Cystaran for corneal cystine crystals

Oct. 5, 2012

Novo Nordisk's insulin degludec obtains first approval

Oct. 2, 2012

Dacogen gains approval in the E.U. for acute myeloid leukemia

Oct. 2, 2012

Suini approved in Japan for type 2 diabetes

Oct. 2, 2012

Plavix gets Japanese approval for additional indication

Oct. 2, 2012

FDA expands approval of Venofer to pediatric patients

Oct. 1, 2012

Dainippon Sumitomo Pharma obtains approval for Aimix combination tablets

Oct. 1, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...